nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbutaline—Clenbuterol—NGF—Parkinson's disease	0.0826	0.43	CrCbGaD
Terbutaline—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Parkinson's disease	0.0502	0.0621	CbGpPWpGaD
Terbutaline—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—Parkinson's disease	0.0427	0.0528	CbGpPWpGaD
Terbutaline—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—Parkinson's disease	0.0424	0.0525	CbGpPWpGaD
Terbutaline—Isoprenaline—ADRBK1—Parkinson's disease	0.0373	0.194	CrCbGaD
Terbutaline—Epinephrine—ADRBK1—Parkinson's disease	0.0314	0.163	CrCbGaD
Terbutaline—Phenylephrine—MAOA—Parkinson's disease	0.0181	0.0941	CrCbGaD
Terbutaline—ADRB2—Monoamine GPCRs—HTR1A—Parkinson's disease	0.0172	0.0213	CbGpPWpGaD
Terbutaline—ADRB2—Monoamine GPCRs—DRD1—Parkinson's disease	0.0166	0.0206	CbGpPWpGaD
Terbutaline—ADRB2—Monoamine GPCRs—DRD3—Parkinson's disease	0.0161	0.02	CbGpPWpGaD
Terbutaline—Clenbuterol—TNF—Parkinson's disease	0.016	0.0833	CrCbGaD
Terbutaline—BCHE—Synthesis, secretion, and deacylation of Ghrelin—INS—Parkinson's disease	0.015	0.0186	CbGpPWpGaD
Terbutaline—ADRB2—Monoamine GPCRs—DRD2—Parkinson's disease	0.0146	0.018	CbGpPWpGaD
Terbutaline—ADRB2—Monoamine GPCRs—HTR7—Parkinson's disease	0.0146	0.018	CbGpPWpGaD
Terbutaline—ADRB2—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.0145	0.0179	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—ATP6AP2—Parkinson's disease	0.014	0.0174	CbGpPWpGaD
Terbutaline—ADRB2—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.014	0.0173	CbGpPWpGaD
Terbutaline—ADRB2—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.0136	0.0168	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—HCN3—Parkinson's disease	0.0125	0.0154	CbGpPWpGaD
Terbutaline—ADRB2—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.0123	0.0152	CbGpPWpGaD
Terbutaline—ADRB2—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.0123	0.0152	CbGpPWpGaD
Terbutaline—ADRB2—Calcium Regulation in the Cardiac Cell—GRK6—Parkinson's disease	0.0117	0.0145	CbGpPWpGaD
Terbutaline—BCHE—Glycerophospholipid biosynthesis—PLA2G6—Parkinson's disease	0.0112	0.0139	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 signaling events—HGF—Parkinson's disease	0.011	0.0136	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.0105	0.013	CbGpPWpGaD
Terbutaline—ADRB2—Monoamine GPCRs—HTR2A—Parkinson's disease	0.0102	0.0126	CbGpPWpGaD
Terbutaline—ADRB2—Calcium Regulation in the Cardiac Cell—GRK5—Parkinson's disease	0.00967	0.012	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00905	0.0112	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Other—ADORA2A—Parkinson's disease	0.00882	0.0109	CbGpPWpGaD
Terbutaline—ADRB2—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00858	0.0106	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00823	0.0102	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—KCNJ4—Parkinson's disease	0.00803	0.00994	CbGpPWpGaD
Terbutaline—BCHE—Phospholipid metabolism—PLA2G6—Parkinson's disease	0.00784	0.00971	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Other—DRD3—Parkinson's disease	0.00716	0.00886	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00708	0.00876	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00705	0.00873	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—DLG1—Parkinson's disease	0.00693	0.00858	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—ADORA2A—Parkinson's disease	0.00689	0.00853	CbGpPWpGaD
Terbutaline—Epinephrine—TNF—Parkinson's disease	0.00673	0.035	CrCbGaD
Terbutaline—ADRB2—GPCRs, Other—HTR7—Parkinson's disease	0.00648	0.00802	CbGpPWpGaD
Terbutaline—ADRB2—Arf6 trafficking events—INS—Parkinson's disease	0.00611	0.00756	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00602	0.00745	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00583	0.00722	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—DRD1—Parkinson's disease	0.00577	0.00715	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—GRIK1—Parkinson's disease	0.00542	0.00671	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GPR37—Parkinson's disease	0.00537	0.00664	CbGpPWpGaD
Terbutaline—ADRB2—G alpha (s) signalling events—HTR7—Parkinson's disease	0.00506	0.00626	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00461	0.00571	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—GRIK2—Parkinson's disease	0.00461	0.00571	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00454	0.00562	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Other—HTR2A—Parkinson's disease	0.00454	0.00561	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—SLC18A2—Parkinson's disease	0.00447	0.00553	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00423	0.00524	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00415	0.00514	CbGpPWpGaD
Terbutaline—BCHE—Peptide hormone metabolism—INS—Parkinson's disease	0.00414	0.00513	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00405	0.00501	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00397	0.00491	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—HSPA9—Parkinson's disease	0.00392	0.00486	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00388	0.0048	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00383	0.00474	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00382	0.00473	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GRM4—Parkinson's disease	0.00365	0.00452	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—CHRNA4—Parkinson's disease	0.00353	0.00438	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—PENK—Parkinson's disease	0.00346	0.00428	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00333	0.00412	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00328	0.00407	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00325	0.00402	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—HSPA8—Parkinson's disease	0.00324	0.00401	CbGpPWpGaD
Terbutaline—BCHE—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00323	0.004	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00321	0.00398	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—PDYN—Parkinson's disease	0.00316	0.00392	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00311	0.00385	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—DLG4—Parkinson's disease	0.00304	0.00376	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00303	0.00375	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—GRIN2B—Parkinson's disease	0.00297	0.00368	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—GRM5—Parkinson's disease	0.00294	0.00364	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—SLC6A3—Parkinson's disease	0.00293	0.00363	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00285	0.00353	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00281	0.00348	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00281	0.00348	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00281	0.00347	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—RPL6—Parkinson's disease	0.0028	0.00346	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GPR37—Parkinson's disease	0.00275	0.00341	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—DGKQ—Parkinson's disease	0.00275	0.00341	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00275	0.00341	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00267	0.0033	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.00265	0.00328	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00253	0.00313	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00252	0.00312	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.0025	0.0031	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—COMT—Parkinson's disease	0.00249	0.00308	CbGpPWpGaD
Terbutaline—BCHE—Neuronal System—MAOA—Parkinson's disease	0.00247	0.00306	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—DCTN1—Parkinson's disease	0.00242	0.003	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00241	0.00298	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00241	0.00298	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ND3—Parkinson's disease	0.00238	0.00294	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MCCC1—Parkinson's disease	0.00238	0.00294	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	0.0023	0.00285	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—OMD—Parkinson's disease	0.00224	0.00277	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TALDO1—Parkinson's disease	0.00224	0.00277	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	0.00217	0.00269	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	0.00214	0.00265	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NDUFB11—Parkinson's disease	0.00212	0.00262	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—RPL23A—Parkinson's disease	0.00212	0.00262	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—RPL14—Parkinson's disease	0.00212	0.00262	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	0.0021	0.00259	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.00209	0.00258	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	0.00206	0.00255	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.00203	0.00251	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GCH1—Parkinson's disease	0.00202	0.0025	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—RPS8—Parkinson's disease	0.00198	0.00245	CbGpPWpGaD
Terbutaline—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00197	0.00244	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.00196	0.00243	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.00195	0.00242	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00193	0.00239	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.00187	0.00232	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.00184	0.00227	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.00184	0.00227	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00182	0.00226	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—DBH—Parkinson's disease	0.0018	0.00223	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GBA—Parkinson's disease	0.0018	0.00223	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—FBP1—Parkinson's disease	0.0018	0.00223	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.00179	0.00221	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.00178	0.0022	CbGpPWpGaD
Terbutaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00169	0.00209	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.00166	0.00206	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.00163	0.00201	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.00163	0.00201	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.00162	0.00201	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.00151	0.00187	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00149	0.00184	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00141	0.00175	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—DDC—Parkinson's disease	0.00132	0.00164	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	0.0013	0.00161	CbGpPWpGaD
Terbutaline—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	0.00129	0.00159	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00128	0.00159	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTA4—Parkinson's disease	0.00125	0.00155	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00123	0.00153	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	0.00123	0.00153	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00123	0.00152	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	0.00121	0.00149	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	0.00118	0.00147	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—IGF2—Parkinson's disease	0.00118	0.00146	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	0.00115	0.00142	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—PLA2G6—Parkinson's disease	0.00112	0.00139	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	0.00111	0.00138	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MAOB—Parkinson's disease	0.00111	0.00138	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	0.00111	0.00137	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	0.0011	0.00136	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	0.00108	0.00133	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00107	0.00133	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00106	0.00131	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAG—Parkinson's disease	0.00105	0.0013	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PENK—Parkinson's disease	0.00105	0.0013	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	0.00104	0.00129	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	0.00104	0.00128	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	0.00104	0.00128	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000973	0.0012	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	0.000959	0.00119	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	0.000942	0.00117	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	0.000942	0.00117	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	0.000902	0.00112	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	0.000892	0.0011	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	0.00083	0.00103	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2D6—Parkinson's disease	0.000828	0.00102	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CTGF—Parkinson's disease	0.000812	0.00101	CbGpPWpGaD
Terbutaline—BCHE—Metabolism of proteins—INS—Parkinson's disease	0.000782	0.000968	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	0.000782	0.000968	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000758	0.000938	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYP2E1—Parkinson's disease	0.000757	0.000937	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	0.000754	0.000934	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—NQO1—Parkinson's disease	0.000748	0.000926	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—TH—Parkinson's disease	0.000738	0.000913	CbGpPWpGaD
Terbutaline—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000727	0.000899	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—CYCS—Parkinson's disease	0.000708	0.000877	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—INSR—Parkinson's disease	0.0007	0.000866	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—FGB—Parkinson's disease	0.000661	0.000819	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	0.00066	0.000817	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	0.000658	0.000814	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	0.000648	0.000802	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	0.000635	0.000786	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—COMT—Parkinson's disease	0.000627	0.000776	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTP1—Parkinson's disease	0.000624	0.000773	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MAOA—Parkinson's disease	0.000623	0.000771	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—HMOX1—Parkinson's disease	0.000616	0.000762	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	0.000615	0.000762	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—ABCB1—Parkinson's disease	0.000591	0.000731	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000575	0.000711	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GSTM1—Parkinson's disease	0.000574	0.00071	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	0.000556	0.000689	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	0.000556	0.000689	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—GPX1—Parkinson's disease	0.000549	0.00068	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—MTHFR—Parkinson's disease	0.000507	0.000628	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—APOE—Parkinson's disease	0.000472	0.000584	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	0.000466	0.000577	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	0.000451	0.000558	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	0.000446	0.000551	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—NGF—Parkinson's disease	0.000409	0.000507	CbGpPWpGaD
Terbutaline—BCHE—Metabolism—INS—Parkinson's disease	0.000403	0.000499	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	0.00039	0.000482	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—APOE—Parkinson's disease	0.000362	0.000448	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—INS—Parkinson's disease	0.00031	0.000383	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	0.00023	0.000285	CbGpPWpGaD
Terbutaline—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	0.000229	0.000283	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	0.000212	0.000262	CbGpPWpGaD
Terbutaline—ADRB2—Signaling Pathways—IL6—Parkinson's disease	0.000135	0.000167	CbGpPWpGaD
